indazoles has been researched along with px 478 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garber, K | 1 |
| Koh, MY; Powis, G; Spivak-Kroizman, TR | 1 |
| Ban, HS; Nakamura, H; Uto, Y | 1 |
2 review(s) available for indazoles and px 478
| Article | Year |
|---|---|
HIF-1alpha and cancer therapy.
Topics: Animals; Cell Hypoxia; Histone Deacetylase Inhibitors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Mustard Compounds; Neoplasms; Phenylpropionates; Proto-Oncogene Proteins c-myc; Tumor Suppressor Protein p53 | 2010 |
Hypoxia-inducible factor inhibitors: a survey of recent patented compounds (2004 - 2010).
Topics: Animals; Antineoplastic Agents; Disulfides; Estradiol; Furans; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Indazoles; Mustard Compounds; Patents as Topic; Phenylpropionates; Piperazines | 2011 |
1 other study(ies) available for indazoles and px 478
| Article | Year |
|---|---|
New drugs target hypoxia response in tumors.
Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase I as Topic; DNA-Binding Proteins; Drugs, Investigational; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Mustard Compounds; Neoplasms; Neovascularization, Pathologic; Nuclear Proteins; Phenylpropionates; Topotecan; Transcription Factors; Transplantation, Heterologous | 2005 |